Boldine: a potential new antiproliferative drug against glioma cell lines
Daniéli Gerhardt1, Ana Paula Horn, Mariana Maier Gaelzer
1Programa de Pós graduação em Ciências Biológicas: Bioquímica, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Rua Ramiro Barcelos 2600, 90035.003, Porto Alegre, RS, Brazil.
Abstract:
Malignant gliomas are the most common and devastating primary tumors of the central nervous system. Currently no efficient treatment is available. This study evaluated the effect and underlying mechanisms of boldine, an aporphine alkaloid of Peumus boldus, on glioma proliferation and cell death. Boldine decreased the cell number of U138-MG, U87-MG and C6 glioma lines at concentrations of 80, 250 and 500 muM. We observed that cell death caused by boldine was cell-type specific and dose-dependent. Exposure to boldine for 24 h did not activate key mediators of apoptosis. However, it induced alterations in the cell cycle suggesting a G(2)/M arrest in U138-MG cells. Boldine had no toxic effect on non-tumor cells when used at the same concentrations as those used on tumor cells. Based on these results, we speculate that boldine may be a promising compound for evaluation as an anti-cancer agent.
Insights
Boldine, a natural compound, effectively reduces glioma cell numbers and induces cell cycle arrest in malignant glioma cells. This compound shows promise as a potential anti-cancer agent with no toxicity to non-tumor cells.
Area of Science:
- Neuro-oncology
- Pharmacology
- Cell Biology
Background:
- Malignant gliomas are aggressive primary brain tumors with limited treatment options.
- There is a critical need for novel therapeutic strategies against these devastating central nervous system tumors.
Purpose of the Study:
- To investigate the anti-glioma effects of boldine, an alkaloid from Peumus boldus.
- To elucidate the mechanisms underlying boldine's impact on glioma cell proliferation and death.
Main Methods:
- Treatment of U138-MG, U87-MG, and C6 glioma cell lines with varying concentrations of boldine.
- Assessment of cell number, cell death, apoptosis mediators, and cell cycle progression.
- Evaluation of boldine's toxicity on non-tumor cells.
Main Results:
- Boldine significantly decreased glioma cell numbers in a dose-dependent manner.
- Cell death induced by boldine was cell-type specific.
- Boldine caused a G(2)/M cell cycle arrest in U138-MG cells without activating key apoptotic mediators.
- Boldine exhibited no toxicity towards non-tumor cells at effective concentrations.
Conclusions:
- Boldine demonstrates significant anti-proliferative and cell cycle-disrupting effects on malignant glioma cells.
- Boldine presents a potential therapeutic candidate for glioma treatment due to its efficacy and selective toxicity.
